Dude, biotech. It takes time (not that I am at all excusing OCC management's tardiness in many areas).
By your own admission you sold out of a huge parcel of OCC, that has FDA, EMA and TGA approvals already, to buy into another biotech that can at best be described as a phase I/II trial stage cancer immunotherapies biotech company, with no approvals, in a hotly contested market saturated by dozens of CAR T-cell and NK cell researching companies globally.
If you are bothered by the wait in OCC, which is further along and has far less arduous pathways, I fear you will be even more frustrated by your investment in the other company and its likely timeline to commercial success.
- Forums
- ASX - By Stock
- OCC
- Next Significant Milestone
Next Significant Milestone, page-30
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.45M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 36.5¢ | $57.69K | 156.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3976 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 670 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3976 | 0.365 |
8 | 134023 | 0.360 |
7 | 44656 | 0.355 |
7 | 59067 | 0.350 |
4 | 108988 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 670 | 1 |
0.375 | 24331 | 1 |
0.380 | 6345 | 2 |
0.385 | 72893 | 2 |
0.390 | 23002 | 5 |
Last trade - 11.46am 21/06/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online